[250 Pages Report] Global Live Cell RNA Detection’ demand is anticipated to be valued at US$ 2,631.8 Million in 2022, forecast to grow at a CAGR of 8.4% to be valued at US$ 6,404.2 Million from 2022 to 2032. Growth is attributed to the increasing funding by the various regulatory bodies and governments globally.
| Report Attribute | Details |
|---|---|
| Growth Rate (2016 to 2021) | 8.5% CAGR |
| Expected Market Value (2022) | US$ 2,631.8 Million |
| Anticipated Forecast Value (2032) | US$ 6,404.2 Million |
| Projected Growth Rate (2022 to 2032) | 8.4% CAGR |
RNA plays an important role in cell and tissue development as well as disease progression thus it is considered to be a major target for analysis of various diseases and disorders. In RNA detection, the study gets done to understand the gene expression patterns and determine the roles of genomic elements in cellular function and dysfunction. In live cell RNA detection, a study of the live cell gets done to understand that how one cell within a population responds to its environment.
In live cell detection various techniques used to detect specific mRNA and microRNA in live cells while leaving the cells undisturbed and intact for further analysis. It also allows dissection of cell in RNA metabolism, RNA transcription, post-transcriptional processing, post-transcriptional regulations, nuclear export and RNA decay.
The growing adoption of high-content screening techniques in drug discovery and rising incidence of cancer primarily drives the market for live cell imaging. In addition, the growth in research funding and rising government funding and investment in regenerative medicine research will also support the market growth in the coming years.
On the other hand, the lack of skilled personnel to perform the detection is expected to hamper the growth of Live Cell RNA Detection Market over the analysis period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing research and development activities in molecular diagnostics sector and increasing availability of various new methodology and techniques are the major factors that are expected to boost the growth of the live cell RNA detection market during the forecast period.
Factors such as the increasing applications of RNA detection techniques in the genetic disorder detection and the increasing prevalence of cancer diseases are expected to propel the growth of the live cell RNA detection market over the analysis period.
The advantages of live cell RNA detection over the conventional techniques as conventional techniques failed to provide important spatial, temporal information, also anticipated to propel the demand for the live cell RNA detection and boost the growth of the global live cell RNA detection market over the forecast period. The funding by the various regulatory bodies and governments also expected to bolster the growth of the global live cell RNA detection market.
The high cost of reagents and devices required for live cell RNA detection is one of the major factors that is expected to hinder the growth of the live cell RNA detection market during the forecast period.
In addition, the stringent rules and regulatory guidance by the U.S. Food and Drug Administration (FDA), may also hinder the growth of the global live cell RNA detection market.
Moreover, the lack of skilled personnel to perform the detection, and high-content screening systems are also expected to impede the growth of the global live cell RNA detection market during the analysis period.
Principal Consultant
In terms of regional platform, North America holds the largest market share in Live Cell RNA Detection market. The region is expected to surge at over 35.0% share from 2022 to 2032.
North America is expected to fuel the Live Cell RNA Detection market, attributed to the developed laboratory infrastructure and availability of skilled personnel in the region.
According to Future Market Insights, Europe is expected to hold significant growth opportunities for Live Cell RNA Detection, and is expected to reach at a share of 29.0% in 2022.
Europe is expected to witness a significant market growth, owing to the increasing research and development activities along with government support and funding in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
According to Future Market Insights, Asia-Pacific is expected to grow with lucrative growth opportunities for Live Cell RNA Detection Market, and is expected to reach at a significant share of 20.3% in 2022.
Asia-Pacific region accounts for a significant share in Live Cell RNA Detection Market, attributed to the factors such as the government initiatives for research on stem cell therapy, the rising prominence of regenerative medicine research, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.
According to Future Market Insights, Middle East & Africa is expected to provide significant growth opportunities for Live Cell RNA Detection Market, and is expected to reach at a share of 10.3% in 2022.
The developing Live Cell RNA Detection market in the Middle East & Africa is expected to aid in flourishing market during the forecast period, owing to increasing awareness about Live Cell RNA Detection in the region.
There are many prominent market players in the Live Cell RNA Detection Market such as CytoSMART Technologies, INNOMED GmbH, Algorithmic Biologics, Phiab, uFluidix, JPK Instruments AG, and Tzar Labs, among others, that are working hand-in-hand to provide the best-in-class Live Cell RNA Detection for enhancing the global arena. However, there are many global start-ups in the Live Cell RNA Detection Market, that are stepping forward in matching the requirements of the Live Cell RNA Detection domain.
Some of the key participants present in the global Live Cell RNA Detection market include Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., MilliporeSigma, Promega Corporation, Biomol GmbH, Advanced Cell Diagnostics, Inc. and Qiagen Diagnostics, Nikon, and Bruker Corporation, among others.
Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., and MilliporeSigma account for a considerable market size, several regional level players are also operating across key growth regions, particularly in North America.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.4% from 2022 to 2032 |
| Market Value in 2022 | US$ 2,631.8 Million |
| Market Value in 2032 | US$ 6,404.2 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled | Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., MilliporeSigma, Promega Corporation, Biomol GmbH, Advanced Cell Diagnostics, Inc. and Qiagen Diagnostics, Nikon, and Bruker Corporation, among others. |
| Customization | Available Upon Request |
FMI projects the global Live Cell RNA Detection market to expand at an 8.4% value CAGR by 2032
North America is expected to be the most opportunistic Live Cell RNA Detection market, expanding at a 35.0% market share
Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., and MilliporeSigma are some prominent Live Cell RNA Detection players
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Techniques 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Techniques, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Techniques, 2022-2032 5.3.1. Linear Oligonucleotide Probe 5.3.2. Linear FRET Probe 5.3.3. Autoligation FRET Probe 5.3.4. Molecular Beacon 5.3.5. MS2-GFP 5.3.6. Bgl-mCherry 5.3.7. lN-GFP 5.3.8. PUM-HD 5.3.9. Spinach RNA Tracking System 5.4. Y-o-Y Growth Trend Analysis By Techniques, 2017-2021 5.5. Absolute $ Opportunity Analysis By Techniques, 2022-2032 6. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032 6.3.1. Diagnostics 6.3.2. Research and Development 6.3.3. Drug Discovery 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 7. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 7.3.1. Biotechnology Companies 7.3.2. Academic Institutes 7.3.3. Clinical Research Organizations 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 8. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Techniques 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Techniques 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Techniques 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Techniques 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Techniques 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Techniques 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. India 12.2.1.5. Malaysia 12.2.1.6. Singapore 12.2.1.7. Australia 12.2.1.8. New Zealand 12.2.1.9. Rest of APAC 12.2.2. By Techniques 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Techniques 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. MEA Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Techniques 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Techniques 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Live Cell RNA Detection Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Techniques 14.1.2.2. By Application 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Techniques 14.2.2.2. By Application 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Techniques 14.3.2.2. By Application 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Techniques 14.4.2.2. By Application 14.4.2.3. By End User 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Techniques 14.5.2.2. By Application 14.5.2.3. By End User 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Techniques 14.6.2.2. By Application 14.6.2.3. By End User 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Techniques 14.7.2.2. By Application 14.7.2.3. By End User 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Techniques 14.8.2.2. By Application 14.8.2.3. By End User 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Techniques 14.9.2.2. By Application 14.9.2.3. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Techniques 14.10.2.2. By Application 14.10.2.3. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Techniques 14.11.2.2. By Application 14.11.2.3. By End User 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Techniques 14.12.2.2. By Application 14.12.2.3. By End User 14.13. Malaysia 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Techniques 14.13.2.2. By Application 14.13.2.3. By End User 14.14. Singapore 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Techniques 14.14.2.2. By Application 14.14.2.3. By End User 14.15. Australia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Techniques 14.15.2.2. By Application 14.15.2.3. By End User 14.16. New Zealand 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Techniques 14.16.2.2. By Application 14.16.2.3. By End User 14.17. GCC Countries 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Techniques 14.17.2.2. By Application 14.17.2.3. By End User 14.18. South Africa 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Techniques 14.18.2.2. By Application 14.18.2.3. By End User 14.19. Israel 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Techniques 14.19.2.2. By Application 14.19.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Techniques 15.3.3. By Application 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Merck KGaA 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. BioTek Instruments, Inc. 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. Thermo Fisher Scientific, Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Agilent Technologies Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. MilliporeSigma 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Promega Corporation 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Biomol GmbH 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. Advanced Cell Diagnostics, Inc. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Qiagen Diagnostics 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Roche Holding AG 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Live Cell RNA Detection Market
